Healthcare Compliance

HeartFlow Treatment Determination Patent Using Patient-Specific Geometrical Models

The European Patent Office published patent application EP3971906A2 on April 15, 2026, filed by HeartFlow, Inc., covering methods and systems for determining medical treatments using patient-specific geometrical models. The application names inventors SPILKER, Ryan, EBERLE, David, and GRADY, Leo, and includes classifications in healthcare technology and medical imaging. Third parties in designated European states now have notice of the published application and potential opposition rights.

CSEM PPG Method Reduces Venous Pulsatility for Diagnosis

CSEM Centre Suisse d'Electronique et de Microtechnique SA - Recherche et Développement has been granted European Patent EP3991641A1 for a method of determining physiological parameters using photoplethysmography (PPG) signals with reduced venous pulsatility influence. The patent was published on April 15, 2026 and names four inventors: Martin Proença, Philippe Renevey, Damien Ferrario, and Guillaume Bonnier. The invention applies to medical diagnostic applications including cardiovascular monitoring where venous pulsatility artifacts can interfere with accurate physiological measurements. The designation covers 27 EU member states.

Banyan Technologies Spatial Pattern for Anatomical Structures, 15th Apr

European Patent Application EP4346583A1 published April 15, 2026, covering methods and systems for obtaining spatial patterns of anatomical structures, filed by Banyan Technologies AG with inventor Damiano AguzzI. The patent application relates to computer-implemented methods for generating spatial patterns of anatomical structures for surgical and diagnostic applications, classified under A61B 5/107, A61B 5/00, and G06T 7/73. Protection extends across all designated European member states including Germany, France, the United Kingdom, Italy, Spain, and 23 other contracting states.

Kawasaki Robotic Surgical System EP3984488A1, 15 Apr

Kawasaki Jukogyo Kabushiki Kaisha has been granted European Patent EP3984488A1 for a robotic surgical system, published April 15, 2026. The patent lists inventors MIZOHATA Yuichi, SHIMOMURA Nobuyasu, and KOBAYASHI Ayataka, and covers technology under IPC classifications A61B 34/30, A61B 34/37, A61B 17/29, and A61B 34/00 (Diagnosis & Surgery). The designation covers 31 European states including AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, and TR.

Koninklijke Philips X-Ray Dark-Field Phase Contrast Imaging System

Koninklijke Philips N.V. has been granted European Patent Application EP4017366A1 for a system enabling simultaneous X-ray dark-field, phase contrast, and attenuation image acquisition. The patent names six inventors and covers IPC classifications related to radiographic apparatus. The designated states include all EU member states plus other EPC contracting states.

Stryker Surgical Navigation Image Registration Patent, EP4091567A1

The European Patent Office has published patent application EP4091567A1, filed by Stryker European Operations Limited, describing a technique for providing user guidance to obtain registration between patient image data and a surgical tracking system. The application names inventors KÄSEBERG Marc, FINKE Markus, and WINNE Christian, and was published April 15, 2026. Medical device manufacturers and surgical navigation system developers should note this application for its coverage of image registration methods in computer-assisted surgery.

Pose Measurement Chaining for Extended Reality Surgical Navigation Patent

European Patent Office published application EP3858281A1 titled 'Pose Measurement Chaining for Extended Reality Surgical Navigation in Visible and Near Infrared Spectra' on April 15, 2026. The patent application names Globus Medical, Inc. as applicant and Thomas CALLOWAY as inventor, covering A61B classifications related to surgical navigation and extended reality systems. The designation covers all 34 European Patent Convention member states including AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, and TR.

Surgical Tensioning Instruments, Globus Medical, Apr 15

The EPO published patent application EP3991675A2 for Surgical Tensioning Instruments, filed by Globus Medical, Inc. (inventor: MURRAY, Patrick) under IPC classification A61B 17/88. The publication grants exclusive rights to the applicant across 31 designated European states.

EP4153062A1 Ultrasound Guidewire System

The EPO published patent application EP4153062A1 for an ultrasound locatable surgical guidewire system and method, filed by Baylor University and Scott&White Healthcare. Inventors listed include Linda J. Olafsen, Keith E. Schubert, Jeffery S. Olafsen, Samantha Dayawansa, and Jason H. Huang. The application covers A61B 8/08 and A61B 8/12 classifications and designates all EPC contracting states.

Retinal Irradiance Distribution Modification Devices, Apr 15

The European Patent Office published patent application EP4259054A1 by APERTURE IN MOTION, LLC covering devices and methods for modifying retinal irradiance distribution to improve and restore vision without producing corneal vitrification. The patent names Olivia N. Serdarevic as inventor and was published April 15, 2026, with designation extending to 36 European states. This represents a new intellectual property filing in the vision correction and medical device space with potential implications for competitors in the ophthalmic technology sector.

Hexacath Catheter Patent, Thermodilution Blood Flow Determination

The European Patent Office published patent application EP4164520A1 for Hexacath's dual-action catheter system combining thermodilution blood flow measurement with body obstruction destruction capability. Named inventors are Gilles Ascher, Bernard De Bruyne, and Nico Pijls. The patent covers 32 designated European member states including Germany, France, the United Kingdom, Italy, Spain, and the Netherlands.

ONDCP 60-Day PRA Comment Request: DFC and CARA Grant Programs

ONDCP published a 60-day Paperwork Reduction Act notice requesting public comments on revisions to two approved information collections: the Drug-Free Communities (DFC) Support Program and the Community-Based Coalition Enhancement Grants to Address Local Drug Crisis (CARA) Local Drug Crisis Program National Evaluation. The notice announces ONDCP's intent to submit revised collections to OMB's Office of Information and Regulatory Affairs. Comments are accepted for 60 days from the April 23, 2026 publication date.

Boston Scientific Neuromodulation Deep Brain Stimulation Patent EP4475937A1

The European Patent Office published patent application EP4475937A1 for Boston Scientific Neuromodulation Corporation, titled 'Automated Selection of Electrodes and Stimulation Parameters in a Deep Brain Stimulation System Using Sensed Neural Potentials.' The patent application, filed with six named inventors, covers neural potential sensing technology for automated electrode and stimulation parameter selection in deep brain stimulation systems. Designated states include AT, BE, DE, FR, GB, IT, NL, and other EPC contracting states.

AI Predicts Pathogen Mutation Evolution, EP2024218557A1

The EPO published patent application EP2024218557A1 for an artificial intelligence-based method and system for predicting mutation trajectories of pathogen evolution. The application, classified under G16H 50/80 (Health Informatics; Models for detecting or predicting disease outbreak risk), was published on April 15, 2026. Inventors have not yet been designated; the application covers designated contracting states including Germany, France, United Kingdom, Italy, Spain, and other EPC member states.

European Patent EP4453865A1, Composite Camera Images, Body Surface Area Modeling, Philips

The European Patent Office granted patent EP4453865A1 to Koninklijke Philips N.V. on April 15, 2026. The patent covers a system for creating composite camera images used in body surface area modeling and de-identification of patients in ultrasound imaging exams. Inventors named are ERRICO, BHARAT, MANKOVICH, STAROBINETS, and PREVRHAL.

Philips Remote Screen Overlay for Radiology Collaboration, Apr 15

The European Patent Office published application EP4566276A1 titled 'Vendor-Agnostic Remote-Controlled Screen Overlay for Collaboration in a Virtualized Radiology Environment,' filed by Koninklijke Philips N.V. with inventor Thomas Erik Amthor. The patent covers remote screen overlay technology enabling real-time collaboration in virtualized radiology environments, classified under IPC codes including H04N and G16H (health informatics). The application received a favourable search report (Kind A1) and designates all EU member states plus several additional European jurisdictions.

European Patent for Hypertension Management Using Wearable Device

The European Patent Office published patent application EP2024111722A1 filed by Meta Therapeutics Inc. on April 15, 2026, covering a system for providing hypertension management services using a wearable device with health monitoring sensors. This publication establishes prior art and creates intellectual property rights in the specified field across designated EPO member states including Germany, France, Italy, the Netherlands, and the United Kingdom. Competitors in digital health and medical device sectors should conduct freedom-to-operate analyses and monitor this application as it progresses through the examination process.

European Patent EP4027620A1 - Long-Term ECG Monitoring System, Bardy Diagnostics

The European Patent Office granted Patent EP4027620A1 to Bardy Diagnostics, Inc. on April 15, 2026, covering a system and method for long-term patient monitoring of continuous ECG and physiological data. The patent application lists inventors BARDY, Gust H., DREISBACH, Ezra M., DAW, Shawni L., and BOLEYN, Rodney. The patent is classified under IPC H04L 67/12 (networked monitoring systems) and G16H 10/60, G16H 40/63, G16H 40/67 (health informatics), with designated states covering 36 European jurisdictions.

DexCom Continuous Analyte Monitoring System Sensor Insertion Patent EP4307316A2

The European Patent Office published patent application EP4307316A2 for DexCom, Inc., covering indicator and analytics for sensor insertion in continuous analyte monitoring systems. The patent was published April 15, 2026, listing inventors Katherine Yerre Koehler, Leif N. Bowman, Rian Draeger, Laura Dunn, and Eli Reihman. The invention is classified under G16H (Health Informatics) and A61B (measuring for diagnostic purposes), with designated states covering all EU member states plus Switzerland, Norway, and other European countries.

EP4341444A1 Cancer Classification Silent Non-Silent Mutations

The European Patent Office published application EP4341444A1 on April 15, 2026, titled 'Cancer Classification and Prognosis Based on Silent and Non-Silent Mutations.' The applicants are Ramot at Tel-Aviv University Ltd. and the inventors are Tamir Tuller and Tal Gutman. The patent covers methods for classifying and predicting cancer outcomes by analyzing both silent and non-silent mutations in genetic sequences, with applications in diagnostic and prognostic testing for various cancer types.

Digital Augmented Reality Psychiatric Management System

The European Patent Office published application EP4374386A1 for systems and methods managing psychiatric or mental conditions using digital or augmented reality. The application, filed by Behavr, LLC and FrontAct Co., Ltd., was published April 15, 2026 under IPC classifications G16H 20/70 and A61B 5/16. The designation covers all EU member states including AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, and TR.

AI-Assisted Medical Image Annotation Systems, EP4323975A1

The EPO published patent application EP4323975A1 for AI-assisted medical image annotation systems filed by Kaliber Labs Inc. on April 15, 2026. The application carries nine IPC classifications covering medical image processing (G06T 7/00), computer vision (G06V 10/74, G06V 10/82), health informatics (G16H 15/00, G16H 30/40), and neural network technologies (G06N 3/088, G06N 3/045, G06N 3/0442, G06N 3/09). The patent is designated across 38 European states including Germany, France, the United Kingdom, Italy, Spain, and the Netherlands.

Neural Network Aneurysm Detection Patent EP4475744A1, Apr 15

The European Patent Office granted patent EP4475744A1 to Microvention, Inc. for a neural network apparatus used in aneurysm identification, segmentation, and treatment outcome prediction. The patent application lists nine inventors and covers multiple IPC classifications in the G16H health informatics category along with G06T image analysis classifications. Designated states include most EU member states plus Switzerland, Norway, and other European countries.

EPO Patent EP4243032A2 - CGM Hypoglycemia Prevention via Insulin Delivery

The EPO published European patent application EP4243032A2 for a CGM-based hypoglycemia prevention system filed by the University of Virginia Patent Foundation. The system, invented by Boris P. Kovatchev, Marc D. Breton, and Stephen D. Patek, performs hypoglycemia risk assessment to enable smooth reduction of insulin delivery. The application was published on 15 April 2026 with designations covering 31 European states.

Summer EBT 2026 Benefit Levels Adjusted

USDA's Food and Nutrition Service has published the 2026 Summer EBT benefit levels under Section 13A of the Richard B. Russell National School Lunch Act (42 U.S.C. 1762), effective January 1 through December 31, 2026. The adjustment reflects a 0.49% increase in the Thrifty Food Plan for the contiguous 48 states and DC, resulting in monthly benefits remaining at $40 ($120 total summer), while Alaska, Hawaii, and U.S. Territories received higher adjustments ranging from 1.69% to 6.20% based on regional TFP cost differences. Alaska Urban rises to $54/month ($162 summer), Alaska Rural I to $69/month ($207 summer), Alaska Rural II to $84/month ($252 summer), Hawaii to $63/month ($189 summer), and U.S. Territories to $60/month ($180 summer).

Food Price Data Collection Study Non-Contiguous States and Territories

The USDA Food and Nutrition Service has published a notice under the Paperwork Reduction Act inviting public comment on a new information collection request for the Food Price Data Collection in the Non-Contiguous States and U.S. Territories Study. The study will collect food price data in Alaska, American Samoa, the Commonwealth of the Northern Mariana Islands, Hawaii, Guam, Puerto Rico, and the U.S. Virgin Islands using retailer data, WIC EBT data, web-scraped data, and in-store surveys. Comments must be submitted by June 8, 2026.

USDA Income Eligibility Guidelines for Child Nutrition Programs, FY2027

USDA's Food and Nutrition Service has published the annual Income Eligibility Guidelines for child nutrition programs, effective July 1, 2026 through June 30, 2027. These guidelines, required by Section 9 of the Richard B. Russell National School Lunch Act, determine income thresholds for free meals (130% of Federal poverty level) and reduced-price meals (185% of FPL) across all participating school districts, childcare facilities, and summer meal programs. The updated figures represent a 2.6 percent increase over last year's levels for a family of four in the 48 contiguous States and DC, based on the Consumer Price Index. State agencies and Indian Tribal Organizations administering the Summer EBT for Children Program must apply these new thresholds when determining household eligibility beginning July 1, 2026.

FDA Proposes Adding Constituents to Tobacco HPHC List

The FDA published a Federal Register notice on April 23, 2026, announcing a proposal to add new constituents to the Established List of Harmful and Potentially Harmful Constituents (HPHC) in tobacco products and tobacco smoke. The document, identified as Docket No. FDA-2026-N-2642 and cited at 91 FR 21824, initiates a 33-day public comment period closing May 26, 2026. Interested parties may submit comments via Regulations.gov or through the Federal Register docket portal.

Algeria Certified Trachoma-Free, 10th African Country, 29th Globally

The World Health Organization has validated Algeria as having eliminated trachoma as a public health problem, making it the 10th country in WHO's African Region and the 29th country globally to achieve this milestone. Algeria submitted its elimination dossier in December 2025 following WHO-compliant surveys in 2022 that confirmed elimination thresholds were met. WHO recommends continued surveillance post-validation to monitor for potential resurgence in previously endemic areas.

Bahamas Certified for Eliminating Mother-to-Child HIV Transmission

The Bahamas has become the 13th country or territory in the WHO Region of the Americas to be certified for eliminating mother-to-child transmission of HIV. The certification confirms sustained achievement of three WHO benchmarks: transmission rate below 2%, fewer than 5 new pediatric HIV infections per 1000 live births, and 95% or higher coverage of antenatal care, HIV testing, and antiretroviral treatment for pregnant women. The milestone was achieved through universal antenatal care regardless of nationality or legal status, integrated laboratory networks, pre-exposure prophylaxis (PrEP) provision, multi-month dispensing of antiretrovirals, and free STI treatment and family planning services.

WHO Reports Measurable Health Impact in 2025 Amid Transition to New Strategy

The World Health Organization released its 2025 Results Report showing that 567 million additional people were covered by essential health services without catastrophic health spending in 2025, compared with the 2018 baseline—an increase of 136 million since 2024. The report also documents 698 million additional people better protected from health emergencies and 1.75 billion additional people living healthier lives. Despite this progress, WHO cautions that the world remains off track to meet health-related Sustainable Development Goals by 2030, with approximately half of output indicators not achieved due to financial pressures and the organization's realignment process.

Cereulide Toxin in Infant Formula, 144 Cases, 99 Countries

WHO has published a Disease Outbreak News report on multi-country infant formula contamination with cereulide toxin, a heat-stable emetic toxin produced by Bacillus cereus. Contaminated arachidonic acid (ARA) oil used as an ingredient in infant formula has been distributed to 99 countries and territories across six WHO Regions, with recalls initiated on 10 December 2025. Between 1 January and 25 February 2026, 144 suspected and confirmed cases were reported across 10 countries, with Belgium reporting 8 laboratory-confirmed cases. WHO assesses the overall public health risk as Moderate due to infant vulnerability, ongoing uncertainty about full product distribution and root cause, and gaps in case detection.

First Imported Human Case Avian Influenza A(H9N2) Italy Senegal Origin

Italy's National IHR Focal Point notified WHO on 21 March 2026 of a human case of avian influenza A(H9N2) in an adult male who had resided in Senegal for more than six months before traveling to Italy in mid-March. Next-generation sequencing confirmed the H9N2 subtype, with genetic analysis showing close similarity to strains previously identified in poultry in Senegal. This is the first imported human case of avian Influenza A(H9N2) reported in the European Region. No direct animal exposure was identified, and all traced contacts in Italy tested negative. WHO assesses the current risk to the general population as low.

FAO-WMO Report: Extreme Heat Threatens 1B+ People, Crops, Livestock

FAO and WMO jointly published a report titled "Extreme heat and agriculture" documenting that extreme heat currently threatens the livelihoods and health of over one billion people, causing approximately 500 billion work hours lost annually. The report details compound climate effects — including flash droughts, wildfires, and pest outbreaks — that amplify damage to livestock, crops, fisheries, and forests. It offers adaptation strategies such as early warning systems, adjusted planting windows, selective breeding, and improved access to financial services, while noting that socioeconomic barriers in low- and middle-income countries limit implementation.

FAO APRC38 Conference: Asia-Pacific Food Security Discussion

FAO Director-General QU Dongyu opened the APRC38 conference in Bandar Seri Begawan, Brunei Darussalam on April 23, 2026, convening ministers from across Asia and the Pacific to negotiate collaboration pathways with FAO. The conference aims to harness the region's increasingly prosperous and dynamic agricultural capacities to bolster food security while ensuring smallholders—constituting 80 percent of all agricultural producers in the region—benefit from technology and trade. Agenda priorities include affordable and nutritious diets, low-emission agricultural practices, trade facilitation, and mobilizing finance directed to smallholder producers.

FAO, Wikimedia Partner to Expand Public Food Knowledge

The Food and Agriculture Organization of the United Nations (FAO) has signed a Memorandum of Understanding with Wikimedia Sverige and Wikimedia UK to expand public access to food, agriculture, and related knowledge through Wikipedia and associated Wikimedia platforms. The five-year agreement formalises an existing informal collaboration, integrating FAO's open-access publications—which include content on food security, agriculture, fisheries, forestry, and nutrition—under Creative Commons Attribution (CC BY 4.0) licensing into one of the world's most widely used information sources. FAO becomes one of the first United Nations agencies to formalise collaboration with Wikimedia chapters, supporting multilingual content across Wikipedia's 300+ language communities.

OSHA Gear Certification OMB Extension, Comments Solicited

OSHA is soliciting public comments on extending OMB approval of information collection requirements under the Standard on Gear Certification (29 CFR 1919). The agency requests a burden hour increase of 20 hours (from 109 to 129 hours) due to an increase in certifications from 5,000 to 6,187. The notice affects 629 respondents with an estimated cost of $3,243,500. Comments must be submitted by June 22, 2026.

FDA Amends CNPV Voucher Pilot Program Hearing, Changes Dates

The FDA has amended its March 23, 2026 notice of public hearing for the Commissioner's National Priority Voucher (CNPV) Pilot Program. The hearing date has been moved from June 12, 2026 to June 4, 2026, 1:00 p.m. to 4:00 p.m. Eastern Time, with both in-person and virtual participation options. Requests for participation must now be received by April 24, 2026. Contact information has been updated to Mallika Mundkur, Deputy Chief Medical Officer, Office of the Commissioner. No other substantive changes have been made to the original notice.

National Heart Lung and Blood Institute Notice of Closed Meeting

The National Heart, Lung, and Blood Institute (NHLBI) has published notice of a closed meeting of the National Heart, Lung, and Blood Advisory Council scheduled for June 9, 2026, from 12:00 p.m. to 4:00 p.m. The meeting will be held in person at the NIH Claude D. Pepper Building, 31 Center Drive, Bethesda, MD 20894. The meeting is closed to the public pursuant to sections 552b(c)(4) and 552b(c)(6) of Title 5 U.S.C. to review and evaluate grant applications containing confidential trade secrets, commercial property, and personal information. Charisee Lamar, Ph.D., M.P.H., R.R.T., Director, Division of Extramural Research Activities, is the contact person.

NIH Center for Scientific Review Announces Four Closed Grant Review Meetings, May–June 2026

The NIH Center for Scientific Review published a notice announcing four closed advisory committee meetings scheduled between May 28 and June 11, 2026. The meetings will review grant applications for cancer therapeutics and mammalian models (May 28), cellular signaling systems (June 2), basic visual neuroscience (June 4), and combined cardiovascular biology and hematology (June 11). All meetings will be held virtually and are closed to the public pursuant to Federal Advisory Committee Act exemptions for confidential trade secrets, commercial property, and personal privacy.

10-Year Import Ban Kimberly Schaff Kiehl Final Debarment Order

The FDA has issued a final order debarring Kimberly Schaff Kiehl for 10 years from importing or offering for import any drug into the United States under section 306 of the FD&C Act. The debarment is based on Ms. Kiehl's July 3, 2025 conviction in the U.S. District Court for the Middle District of Florida on two federal felonies: mail fraud and causing counterfeit drugs to be made, sold, or held for sale. Ms. Kiehl was the registered agent and authorized member of Focus Beauty, LLC, which marketed and sold drugs via a website. She imported drugs from China and other foreign countries between January 2020 and September 2021, and received prior notices from the FDA and CBP about the violative nature of her imports. Ms. Kiehl failed to respond to the proposed debarment notice within 30 days, waiving her right to a hearing. The order is applicable April 23, 2026.

Request of Nominations: U.S. Preventive Services Task Force

AHRQ is soliciting nominations for the U.S. Preventive Services Task Force (USPSTF) by May 23, 2026. The USPSTF, established in 1984 under the Public Health Service Act and supported by AHRQ, is a federal advisory body of prevention and evidence-based medicine experts that makes recommendations on clinical preventive services including screening tests, counseling, and preventive medications. New members appointed by the HHS Secretary will serve four-year terms beginning July 2026, with selections based on qualification and current expertise needs of the Task Force.

Center for Scientific Review Amends Panel Name for May 13-14 Meeting

The NIH Center for Scientific Review has amended a previously published meeting notice (Doc. No. 2026-07338, 91 FR 20473) to change the panel name from 'Training and Career Development: Behavioral Neuroscience' to 'Training and Career Development Review'. The meeting, scheduled for May 13, 2026 from 9:00 a.m. to May 14, 2026 at 6:00 p.m. at the NIH Rockledge II facility in Bethesda, MD, remains closed to the public. The amendment is dated April 21, 2026, signed by Sterlyn H. Gibson, Program Specialist.

National Heart, Lung, and Blood Advisory Council Notice of Open Meeting

The National Heart, Lung, and Blood Advisory Council will hold an open meeting on June 9, 2026, from 8:30 a.m. to 12:00 p.m. at the National Institutes of Health Claude D. Pepper Building in Bethesda, MD. The session will address program policies and issues and is open to the public with attendance limited to space available. Individuals requiring special assistance such as sign language interpretation must notify the Contact Person at least 10 days prior to the meeting.

Ohio Medical Board Schedules April Public Meetings

The State Medical Board of Ohio has published its April 2026 public meeting schedule. Meetings include the Dietetics Advisory Council (April 6, virtual, 2 p.m.), multiple committee sessions and the Board Meeting (April 8, in-person at Rhodes State Office Tower), and the Acupuncture Advisory Council (April 15, virtual, 12 p.m.). Only the April 8 Board Meeting will be livestreamed on the Board's YouTube channel; committee meetings and advisory council sessions will not be broadcast. Members of the public may access agendas and meeting links via the Board's website.

Ohio Med Board Releases Two Podcast Episodes Featuring Medical Students, Ketamine

The Ohio Medical Board released two new episodes of its Med Board Pulse podcast on April 15, 2026. The first episode features three Ohio University Heritage College of Osteopathic Medicine medical students discussing their transition from medical school to residency as resident physicians. The second episode features Board Member Amol Soin, MD, explaining the use of ketamine in medical practice. The podcast is available via the Med Board Pulse landing page.

Letter from FDA CDER to USPTO, Apr 15

FDA CDER issued correspondence to the USPTO containing two PDF attachments. The primary document body states no documents are available to view or download directly. The attachments appear to be inter-agency communications related to a patent matter filed under docket FDA-2024-E-3588. This type of correspondence typically addresses patent term extension applications, patent listings, or other drug patent-related matters referred by the USPTO.

FDA CTP Complaint, Docket FDA-2026-H-4163

FDA's Center for Tobacco Products filed a complaint in Docket FDA-2026-H-4163 on April 22, 2026. The complaint document is available as an attachment but the main docket page shows no viewable content. This represents a new enforcement filing by FDA's tobacco enforcement division.

FDA CDRH Denial Letter to Olsson Frank Weeda Terman Matz PC, Apr 22

FDA CDRH issued a Final Response Letter on April 22 denying a regulatory petition (FDA-2015-P-2854) submitted by Olsson Frank Weeda Terman Matz PC. The denial letter constitutes a final agency action on the petitioned matter. The specific subject matter and basis for denial are contained in the attachment (Final Response Letter), which is available for download as a PDF.

FDA Approves Redhouse Productions Variance, Apr 22

FDA CDRH issued a variance renewal approval letter to Redhouse Productions on April 22, 2024, extending an existing regulatory variance. The variance renewal allows Redhouse Productions to continue operating under modified regulatory terms for the device or activity covered by the original variance. Variance renewals maintain the holder's existing regulatory flexibility while confirming continued compliance with applicable requirements.